​
​

Monopar Therapeutics Ownership | Who Owns Monopar Therapeutics?

OverviewForecastFinancialsChart

Monopar Therapeutics Ownership Summary

Monopar Therapeutics is owned by 2.62% institutional investors, 42.94% insiders, and 54.45% retail investors. Millennium management is the largest institutional shareholder, holding 1.22% of MNPR shares. Fidelity Extended Market Index is the top mutual fund, with 0.26% of its assets in Monopar Therapeutics shares.

MNPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMonopar Therapeutics2.62%42.94%54.45%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management194.30K1.22%$145.34K
Geode capital management60.04K0.38%$44.91K
Virtu financial18.84K0.12%$14.00K
Wells fargo & company/mn2.50K0.02%$1.82K
Bank of america corp /de/561.000.00%$410.00
Ubs group---
Gerber---
Newedge advisors---
Hrt financial lp---
Fmr---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial18.84K0.00%$14.00K
Millennium management194.30K0.00%$145.34K
Two sigma securities---
Federation des caisses desjardins du quebec---
Bank of america corp /de/561.00-$410.00
Rappaport reiches capital management---
Ubs group---
Gerber---
Newedge advisors---
Wells fargo & company/mn2.50K-$1.82K

Top Buyers

HolderShares% AssetsChange
Geode capital management60.04K-18.84K
Millennium management194.30K0.00%1.92K
Wells fargo & company/mn2.50K-963.00
Bank of america corp /de/561.00-61.00
Federation des caisses desjardins du quebec---80.00

Top Sellers

HolderShares% AssetsChange
Two sigma securities---47.06K
Vanguard group---45.17K
Hrt financial lp---32.11K
Gerber---28.00K
Rappaport reiches capital management---10.70K

Sold Out

HolderChange
Federation des caisses desjardins du quebec-80.00
Morgan stanley-800.00
Ubs group-2.57K
Newedge advisors-3.00K
Fmr-5.50K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202412-20.00%418,1625.80%232.01%6-14.29%1-50.00%
Mar 31, 2024157.14%395,22845.63%277.37%7-12.50%2-
Dec 31, 202314-271,392-9.95%138.11%814.29%2-60.00%
Sep 30, 20231475.00%301,39056.62%2104.16%775.00%5400.00%
Jun 30, 20238-27.27%192,440-16.91%147.02%4-20.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index9.23K0.26%1.05K
Vanguard Institutional Extnd Mkt Idx Tr9.03K0.26%-
Fidelity Nasdaq Composite Index2.69K0.08%-
Fidelity Series Total Market Index2.15K0.06%1.20K
NT Ext Equity Mkt Idx Fd - L663.000.02%-1.00
Northern Trust Extended Eq Market Idx663.000.02%-1.00
SSgA U.S. Extended Market Index Class I1.30K0.01%-
State St US Extended Mkt Indx NL Cl C260.000.00%-
SSgA U.S. Total Market Index Strategy533.000.00%158.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 5102.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 28, 2024Radhakrishnan Karthik Chief Financial OfficerBuy$25.19K
Jun 20, 2024Cittadine Andrew Chief Operating OfficerBuy$15.25K
Jun 18, 2024Cittadine Andrew Chief Operating OfficerBuy$10.32K
Jun 13, 2024Cittadine Andrew Chief Operating OfficerBuy$10.92K
Jun 14, 2024Cittadine Andrew Chief Operating OfficerBuy$11.18K

Insider Transactions Trends

DateBuySell
2024 Q41-
2024 Q3--
2024 Q210-
2024 Q1--
2023 Q4--

MNPR Ownership FAQ

Who Owns Monopar Therapeutics?

Monopar Therapeutics shareholders are primarily institutional investors at 2.62%, followed by 42.94% insiders and 54.44% retail investors. The average institutional ownership in Monopar Therapeutics's industry, Biotech Stocks , is 45.43%, which Monopar Therapeutics falls below.

Who owns the most shares of Monopar Therapeutics?

Monopar Therapeutics’s largest shareholders are Millennium management (194.3K shares, 1.22%), Geode capital management (60.04K shares, 0.38%), and Virtu financial (18.84K shares, 0.12%). Together, they hold 1.71% of Monopar Therapeutics’s total shares outstanding.

Does Blackrock own Monopar Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Monopar Therapeutics.

Who is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 18.84K Monopar Therapeutics shares, valued at 14K$.

Who is the top mutual fund holder of Monopar Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Monopar Therapeutics shares, with 0.26% of its total shares outstanding invested in 9.23K Monopar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools